KORKMAZ, O. T. Et Al. 2010. Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells. JOURNAL OF MOLECULAR NEUROSCIENCE , vol.41, no.2 , 278-287.

KORKMAZ, O. T., Tuncel, N., Tuncel, M., Oncu, E. M., ŞAHİNTÜRK, V., & Celik, M., (2010). Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells. JOURNAL OF MOLECULAR NEUROSCIENCE , vol.41, no.2, 278-287.

KORKMAZ, ORHAN Et Al. "Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells," JOURNAL OF MOLECULAR NEUROSCIENCE , vol.41, no.2, 278-287, 2010

KORKMAZ, ORHAN T. Et Al. "Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells." JOURNAL OF MOLECULAR NEUROSCIENCE , vol.41, no.2, pp.278-287, 2010

KORKMAZ, O. T. Et Al. (2010) . "Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells." JOURNAL OF MOLECULAR NEUROSCIENCE , vol.41, no.2, pp.278-287.

@article{article, author={ORHAN TANSEL KORKMAZ Et Al. }, title={Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells}, journal={JOURNAL OF MOLECULAR NEUROSCIENCE}, year=2010, pages={278-287} }